Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

640 ARTÍCULOS , VIENDO DEL 316 AL 330

Souvenaid in the management of mild cognitive impairment: an expert consensus opinion

Cummings J, Passmore P, McGuinness B, Mok V, Chen C, Engelborghs S, Woodward M, Manzano S, Garcia-Ribas G, Cappa S, Bertolucci P, Chu LW.

Alzheimers Res Ther. 2019 Aug 17;11(1):73. doi: 10.1186/s13195-019-0528-6.

Misdiagnosis leads to Iatrogenesis

Chin AV.

Med J Malaysia. 2019 Aug;74(4):359-362.

Alzheimer's dementia: pathogenesis and impact of cardiovascular risk factors on cognitive decline

Wanleenuwat P, Iwanowski P, Kozubski W.

Postgrad Med. 2019 Sep;131(7):415-422. doi: 10.1080/00325481.2019.1657776. Epub 2019 Aug 27.

Modifiable Risk Factors Explain Socioeconomic Inequalities in Dementia Risk: Evidence from a Population-Based Prospective Cohort Study

Deckers K, Cadar D, van Boxtel MPJ, Verhey FRJ, Steptoe A, Köhler S.

J Alzheimers Dis. 2019;71(2):549-557. doi: 10.3233/JAD-190541.

Diabetes mellitus and risks of cognitive impairment and dementia: A systematic review and meta-analysis of 144 prospective studies

Xue M, Xu W, Ou YN, Cao XP, Tan MS, Tan L, Yu JT.

Ageing Res Rev. 2019 Nov;55:100944. doi: 10.1016/j.arr.2019.100944. Epub 2019 Aug 17.

[Prevention of cognitive decline and dementia by treatment of risk factors]

Escher C, Jessen F.

Nervenarzt. 2019 Sep;90(9):921-925. doi: 10.1007/s00115-019-0759-6.

Vascular cognitive impairment associated with NOTCH3 Exon 33 mutation: A case report

Sun Y, Wei YJ, Xing Y.

Medicine (Baltimore). 2019 Aug;98(34):e16920. doi: 10.1097/MD.0000000000016920.

Dietary Neuroketotherapeutics for Alzheimer's Disease: An Evidence Update and the Potential Role for Diet Quality

Taylor MK, Swerdlow RH, Sullivan DK.

Nutrients. 2019 Aug 15;11(8):1910. doi: 10.3390/nu11081910.

[Visual perceptual disorders in Alzheimer's disease]

Lenoir H, Siéroff É.

Geriatr Psychol Neuropsychiatr Vieil. 2019 Sep 1;17(3):307-316. doi: 10.1684/pnv.2019.0815.

Geospatial Analysis of Environmental Risk Factors for Missing Dementia Patients

Puthusseryppady V, Coughlan G, Patel M, Hornberger M.

J Alzheimers Dis. 2019;71(3):1005-1013. doi: 10.3233/JAD-190244.

Awareness of Self and Disease Assessment: Development and Validation of a Subjective Measure in People with Alzheimer's Disease

Mayelle A, El Haj M, Antoine P.

J Alzheimers Dis. 2019;71(3):841-850. doi: 10.3233/JAD-190371.

Factors Related to Dementia Worry: Comparing Middle-Aged and Older Adults in South Korea

Ryu SI, Park YH.

Res Gerontol Nurs. 2019 Nov 1;12(6):299-310. doi: 10.3928/19404921-20190823-02. Epub 2019 Aug 27.

Do anti-amyloid-β drugs affect neuropsychiatric status in Alzheimer's disease patients?

Panza F, Lozupone M, Bellomo A, Imbimbo BP.

Ageing Res Rev. 2019 Nov;55:100948. doi: 10.1016/j.arr.2019.100948. Epub 2019 Aug 24.

Independent and joint effects of vascular and cardiometabolic risk factor pairs for risk of all-cause dementia: a prospective population-based study

Shaaban CE, Jia Y, Chang CH, Ganguli M.

Int Psychogeriatr. 2019 Oct;31(10):1421-1432. doi: 10.1017/S1041610219001066.

Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly

Pinto TCC, Machado L, Costa MLG, Santos MSP, Bulgacov TM, Rolim APP, Silva GA, Rodrigues-Júnior AL, Sougey EB, Ximenes RCC.

Dement Geriatr Cogn Disord. 2019;47(4-6):366-374. doi: 10.1159/000501308. Epub 2019 Aug 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias